Elevation Wealth Partners’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.7K Buy
427
+388
+995% +$37.2K 0.01% 358
2026
Q1
$4.09K Sell
39
-69
-64% -$7.82K ﹤0.01% 762
2025
Q4
$10.9K Buy
108
+17
+19% +$1.85K ﹤0.01% 469
2025
Q3
$11.2K Buy
91
+1
+1% +$124 ﹤0.01% 380
2025
Q2
$10.8K Hold
90
﹤0.01% 363
2025
Q1
$13.2K Buy
90
+1
+1% +$153 0.01% 346
2024
Q4
$14.4K Buy
89
+1
+1% +$164 0.01% 338
2024
Q3
$14.4K Buy
88
+6
+7% +$889 0.01% 325
2024
Q2
$11.1K Sell
82
-67
-45% -$9.3K 0.01% 339
2024
Q1
$22.9K Buy
149
+2
+1% +$299 0.01% 287
2023
Q4
$19.2K Hold
147
0.01% 285
2023
Q3
$19.2K Buy
147
+1
+0.7% +$152 0.02% 210
2023
Q2
$23.2K Buy
146
+1
+0.7% +$161 0.02% 208
2023
Q1
$22.9K Buy
+145
New +$21.7K 0.02% 210

Other funds holding CLX

Elevation Wealth Partners's CLX Position: Q2 2026 in Review

Elevation Wealth Partners increased its Clorox (CLX) stake by 995% in Q2 2026, buying an estimated $37.2K and bringing the position to 427 shares worth $40.7K. The position accounts for 0.01% of the portfolio, ranked #358.

Elevation Wealth Partners first reported a position in CLX in Q1 2023 and has held it in 14 quarters since. 404 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Elevation Wealth Partners held 427 shares of Clorox worth $40.7K as of Q2 2026.
  • Elevation Wealth Partners bought 388 Clorox shares in Q2 2026, an estimated $37.2K.
  • Clorox made up 0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #358 holding.
  • Elevation Wealth Partners first reported a position in Clorox in Q1 2023 and has held it in 14 quarters since.
  • 404 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.